Publications by authors named "Autumn J McRee"

22Publications

Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET).

Leuk Lymphoma 2019 11 23;60(11):2793-2797. Epub 2019 May 23.

Division of Hematology/Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article and Find Full Text PDF
November 2019

Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.

Nanomedicine 2019 06 8;18:189-195. Epub 2019 Mar 8.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC; Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellent, Carolina Institute of Nanomedicine, University of North Carolina, Chapel Hill, NC. Electronic address:

View Article and Find Full Text PDF
June 2019

Multidisciplinary Approach to the Management of Esophageal Malignancies.

World J Surg 2017 07;41(7):1726-1733

Department of Hematology and Oncology, The University of North Carolina, 170 Manning Drive, CB #7305, Chapel Hill, NC, 27599, USA.

View Article and Find Full Text PDF
July 2017

Checkpoint inhibition for colorectal cancer: progress and possibilities.

Immunotherapy 2016 06;8(6):693-704

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

View Article and Find Full Text PDF
June 2016

A phase I trial of mFOLFOX6 combined with the oral PI3K inhibitor BKM120 in patients with advanced refractory solid tumors.

Invest New Drugs 2015 Dec 21;33(6):1225-31. Epub 2015 Oct 21.

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.

View Article and Find Full Text PDF
December 2015

Everolimus and pasireotide for advanced and metastatic hepatocellular carcinoma.

Invest New Drugs 2015 Apr 23;33(2):505-9. Epub 2015 Jan 23.

Division of Hematology and Oncology, University of North Carolina at Chapel Hill, 170 Manning Drive, CB 7305, Chapel Hill, NC, 27599, USA,

View Article and Find Full Text PDF
April 2015

A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.

Cancer Chemother Pharmacol 2014 Jul 13;74(1):117-23. Epub 2014 May 13.

Department of Medicine, Division of Hematology/Oncology, School of Medicine, The University of North Carolina at Chapel Hill, Physicians Office Building, 170 Manning Drive, Campus Box #7305, Chapel Hill, NC, 27599, USA,

View Article and Find Full Text PDF
July 2014